-+ 0.00%
-+ 0.00%
-+ 0.00%

GT Biopharma Q2 EPS $(0.55) Beats $(0.68) Estimate

Benzinga·08/14/2025 20:42:34
Listen to the news
GT Biopharma (NASDAQ:GTBP) reported quarterly losses of $(0.55) per share which beat the analyst consensus estimate of $(0.68) by 19.12 percent. This is a 74.65 percent increase over losses of $(2.17) per share from the same period last year.